These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Obsessive compulsive disorder is not an anxiety disorder. Montgomery SA Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():57-62. PubMed ID: 8254154 [No Abstract] [Full Text] [Related]
5. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine. Ravindran AV; Lapierre YD; Anisman H Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112 [TBL] [Abstract][Full Text] [Related]
6. [Neuro-pathophysiological hypothesis of obsessive compulsive disorder based on the findings from neuroimaging studies]. Murayama K; Nakao T; Kanba S Fukuoka Igaku Zasshi; 2013 May; 104(5):81-8. PubMed ID: 23885392 [No Abstract] [Full Text] [Related]
7. Is pica in the spectrum of obsessive-compulsive disorders? Gundogar D; Demir SB; Eren I Gen Hosp Psychiatry; 2003; 25(4):293-4. PubMed ID: 12850663 [No Abstract] [Full Text] [Related]
8. Obsessive-compulsive spectrum of disorders: a defensible construct? Castle DJ; Phillips KA Aust N Z J Psychiatry; 2006 Feb; 40(2):114-20. PubMed ID: 16476128 [TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive spectrum disorders in primary care: the possibilities and the pitfalls. Higgins ES J Clin Psychiatry; 1996; 57 Suppl 8():7-9; discussion 9-10. PubMed ID: 8698685 [TBL] [Abstract][Full Text] [Related]
10. Obsessive-compulsive disorder. Veale D; Roberts A BMJ; 2014 Apr; 348():g2183. PubMed ID: 24709802 [No Abstract] [Full Text] [Related]
11. Breakthrough in psychiatric care: pharmacological treatment of obsessive-compulsive disorders with implications for nursing care. Giger JN; Davidhizar R; Poole VL J Pract Nurs; 2002; 52(2):12-6; quiz 17, 21. PubMed ID: 12122747 [No Abstract] [Full Text] [Related]
13. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
14. Obsessive-compulsive spectrum disorders: a multidimensional approach. Stein DJ; Lochner C Psychiatr Clin North Am; 2006 Jun; 29(2):343-51. PubMed ID: 16650712 [TBL] [Abstract][Full Text] [Related]
15. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069 [TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122 [TBL] [Abstract][Full Text] [Related]